Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease. (April 2022)

Record Type:: Journal Article
Title:: Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease. (April 2022)
Main Title:: Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
Authors:: Frey, Sarah
Chiang, Teresa Po-Yu
Connolly, Caoilfhionn M
Teles, Mayan
Alejo, Jennifer L
Boyarsky, Brian J
Christopher-Stine, Lisa
Werbel, William A
Massie, Allan B
Segev, Dorry L
Paik, Julie J
Abstract:
Is Part Of:: Lancet. Volume 4:Number 4(2022)
Journal:: Lancet
Issue:: Volume 4:Number 4(2022)
Issue Display:: Volume 4, Issue 4 (2022)
Year:: 2022
Volume:: 4
Issue:: 4
Issue Sort Value:: 2022-0004-0004-0000
Page Start:: e241
Page End:: e243
Publication Date:: 2022-04
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(21)00417-3 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21284.xml